Terms: = Thyroid cancer AND PAX3, MGC120382, 5077, ENSG00000135903, CDHS, MGC120383, HUP2, P23760, WS1, MGC120384, MGC134778, MGC120381
3 results:
1. Serum miR-658 induces metastasis of gastric cancer by activating pax3-MET pathway: A population-based study.
Wu Y; Wan X; Ji F; Song Z; Fang X
Cancer Biomark; 2018; 22(1):111-118. PubMed ID: 29630524
[TBL] [Abstract] [Full Text] [Related]
2. The prognostic significance of the BRAF V600E mutation in papillary thyroid carcinoma detected by mutation-specific immunohistochemistry.
McKelvie PA; Chan F; Yu Y; Waring P; Gresshoff I; Farrell S; Williams RA
Pathology; 2013 Dec; 45(7):637-44. PubMed ID: 24247620
[TBL] [Abstract] [Full Text] [Related]
3. Common genetic variants related to genomic integrity and risk of papillary thyroid cancer.
Neta G; Brenner AV; Sturgis EM; Pfeiffer RM; Hutchinson AA; Aschebrook-Kilfoy B; Yeager M; Xu L; Wheeler W; Abend M; Ron E; Tucker MA; Chanock SJ; Sigurdson AJ
Carcinogenesis; 2011 Aug; 32(8):1231-7. PubMed ID: 21642358
[TBL] [Abstract] [Full Text] [Related]
